Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SHPRH mRNA | decreases expression | 19150397
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of SHPRH mRNA | decreases expression | 18445702
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SHPRH mRNA | increases expression | 18301758
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of SHPRH mRNA | decreases expression | 16014739
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SHPRH mRNA | decreases expression | 20106945 17101203
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SHPRH mRNA | increases expression | 19465110
|
C025643 |
vinclozolin |
vinclozolin results in decreased expression of SHPRH mRNA | decreases expression | 18042343
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.38 | 15322242 14514962 11752688 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.52 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.77 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.77 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.31 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.51 | 16712894 17306315 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.29 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.93 | 19015723 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
10.04 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
10.04 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.40 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.97 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.67 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.09 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
2.00 | 17306315 15276417 16507464 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.46 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.54 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.52 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
7.52 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.08 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.22 | 16354765 15340226 8697196 12621046 15668235 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.38 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.27 | 20055451 10048152 15322242 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.78 | 14966744 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.56 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.73 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.61 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
3.02 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.79 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.79 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.51 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.37 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.14 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.14 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.94 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.43 | 20067830 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.47 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.91 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.22 | 16452187 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.21 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.49 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.73 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.71 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.92 | 19772884 16221962 19176532 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.92 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.47 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.66 | 8697196 16354765 15340226 18606429 16959395 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.53 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.01 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.60 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
7.60 | 16467254 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
2.01 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.85 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.98 | 20008137 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.27 | 16417039 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.22 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.22 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
8.01 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
8.01 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
8.01 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.31 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.40 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.38 | 15276417 16712894 19931552 17306315 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.38 | 19555203 11884234 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.07 | 16487513 19082730 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.99 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.26 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.31 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.22 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.45 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.45 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.15 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.65 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.36 | 12854658 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.52 | 15276417 17306315 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.86 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
4.00 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
11.35 | 11399792 11118676 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
11.35 | 18042343 18220299 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.47 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.24 | 16039940 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.47 | 18629315 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.53 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.28 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
6.07 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.07 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.07 | 12854658 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.51 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.62 | 17306315 16452187 16712894 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.11 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.96 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.21 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.86 | 15886252 |